Literature DB >> 26122860

Neurodegenerative disease: Could fingolimod provide cognitive benefits in patients with Huntington disease?

Heather Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26122860     DOI： 10.1038/nrneurol.2015.117

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.

Authors:  Andrés Miguez; Gerardo García-Díaz Barriga; Verónica Brito; Marco Straccia; Albert Giralt; Silvia Ginés; Josep M Canals; Jordi Alberch
Journal:  Hum Mol Genet       Date:  2015-06-10       Impact factor: 6.150
  1 in total
  1 in total

Review 1.  Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis.

Authors:  Pablo Bascuñana; Luisa Möhle; Mirjam Brackhan; Jens Pahnke
Journal:  Drugs R D       Date:  2020-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.